Featured
-
Featured
The life sciences and biotech community navigated a historically challenging landscape in 2025. Between shifts in federal agency structures and financial hurdles on Wall Street, the industry faced significant uncertainty. However, innovation has not slowed down. From CRISPR gene-editing breakthroughs to AI-bolstered drug discovery and advances in materials science, the potential for progress remains stronger...
$199
